Trials / Withdrawn
WithdrawnNCT02157545
The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine
The Dose-response Relationship of Rocuronium in Patients Taking Pyridostigmine Preoperatively Compared With Age and Sex Matched Controls
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Shashi Bhatt, MD · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Pyridostigmine is a medication that is used in certain heart rate and blood pressure conditions. This medication, as a side effect, is known to also cause changes in the junction between a nerve and muscle. The changes caused at the nerve muscle junction by pyridostigmine could alter the effect of muscle relaxants (a medication used during surgery and anesthesia). The investigators are conducting this study to see whether patients taking pyridostigmine are more or less sensitive to rocuronium (a muscle relaxing medication used during surgery).
Detailed description
No subjects enrolled. No data collected.
Conditions
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2014-06-06
- Last updated
- 2016-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02157545. Inclusion in this directory is not an endorsement.